Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
18
pubmed:dateCreated
2000-7-6
pubmed:abstractText
A myosin surface loop (amino acids 391-404) is postulated to be an important actin binding site. In human beta-cardiac myosin, mutation of arginine-403 to a glutamine or a tryptophan causes hypertrophic cardiomyopathy. There is a phosphorylatable serine or threonine residue present on this loop in some lower eukaryotic myosin class I and myosin class VI molecules. Phosphorylation of the myosin I molecules at this site regulates their enzymatic activity. In almost all other myosins, the homologous residue is either a glutamine or an aspartate, suggesting that a negative charge at this location is important for activity. To study the function of this loop, we have used site-directed mutagenesis and baculovirus expression of a heavy meromyosin- (HMM-) like fragment of human nonmuscle myosin IIA. An R393Q mutation (equivalent to the R403Q mutation in human beta-cardiac muscle myosin) has essentially no effect on the actin-activated MgATPase or in vitro motility of the expressed HMM-like fragment. Three mutations, D399K, D399A, and a deletion mutation that removes residues 393-402, all decrease both the V(max) of the actin-activated MgATPase by 8-10-fold and the rate of in vitro motility by a factor of 2-3. The K(ATPase) of the actin-activated MgATPase activity and the affinity constant for binding of HMM to actin in the presence of ADP are affected by less than a factor of 2. These data support an important role for the negative charge at this location but show that it is not critical to enzymatic activity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0006-2960
pubmed:author
pubmed:issnType
Print
pubmed:day
9
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5555-60
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:10820029-Actins, pubmed-meshheading:10820029-Amino Acid Sequence, pubmed-meshheading:10820029-Baculoviridae, pubmed-meshheading:10820029-Ca(2+) Mg(2+)-ATPase, pubmed-meshheading:10820029-Cardiomyopathy, Hypertrophic, pubmed-meshheading:10820029-Humans, pubmed-meshheading:10820029-Kinetics, pubmed-meshheading:10820029-Models, Molecular, pubmed-meshheading:10820029-Molecular Motor Proteins, pubmed-meshheading:10820029-Molecular Sequence Data, pubmed-meshheading:10820029-Mutagenesis, Site-Directed, pubmed-meshheading:10820029-Mutation, pubmed-meshheading:10820029-Myosin Subfragments, pubmed-meshheading:10820029-Myosins, pubmed-meshheading:10820029-Protein Binding, pubmed-meshheading:10820029-Recombinant Proteins, pubmed-meshheading:10820029-Sequence Alignment, pubmed-meshheading:10820029-Static Electricity
pubmed:year
2000
pubmed:articleTitle
A conserved negatively charged amino acid modulates function in human nonmuscle myosin IIA.
pubmed:affiliation
Laboratory of Molecular Cardiology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892-1762, USA.
pubmed:publicationType
Journal Article